CEDAR KNOLLS, N.J.,
May 29, 2019 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company")
(NASDAQ: MYOS), an advanced nutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
derived from fertilized egg yolk that helps build lean muscle,
announced their latest endorsement partnership with Carli Lloyd, an American superstar soccer player
and two-time Olympic gold medalist, FIFA Women's World Cup
champion, two-time FIFA Women's Player of the Year and
three-time Olympian. As part of the endorsement partnership, Lloyd
will serve as an endorser of Yolked®, our
NSF Certified for Sport® branded sports
nutrition product, to the millions of soccer fans across the world
and appear in multiple marketing campaigns to promote Yolked, which
is scientifically proven to help build more lean muscle and
decrease muscle loss. Lloyd will be a Captain of the U.S. Women's
World Cup team, her 4th time as a member of the World Cup
squad.
"I'm excited to partner with MYOS and join Team Yolked," said
Lloyd. "Yolked fits well into my daily routine and provides me with
the muscle recovery needed to play as vigorously as I do.
MYOS is on the cutting edge of sports nutrition and I'm proud to
represent a brand that is committed to delivering products that are
made with safe and natural ingredients, while also giving me the
strength, power and endurance to perform at the highest level. I
take advantage of the most wholesome, safe and all-natural products
I can find to keep on playing the sport that I love. I look forward
to spreading the word on how Yolked can help people everywhere see
results and reach new goals."
Joseph Mannello, CEO of MYOS,
commented, "We are thrilled to be working with Carli, a dynamic
superstar, champion, role model and leader. Carli is someone who
transcends sports and possesses a commitment to excellence; we
believe she will be a spectacular ambassador for our Yolked brand.
Carli will play a major role in promoting Yolked through
advertising, public appearances and product endorsements, along
with many additional promotional opportunities including digital
media and editorial content. We're choosing people who have
repeatedly proven themselves as difference-makers. We believe her
endorsement will enable us to broaden our reach and drive increased
adoption of our products."
James Galanis, Carli Lloyd's personal trainer, commented, "I'm
always open to nutritionally sound and proven products that can
help Carli stay at the top of her game. Carli trains
rigorously every day; the physical and mental challenges of top
athletes demand only the safest and most effective support to
achieve their goals and Yolked muscle health formula fits that
profile. Carli plans to exceed her prior achievements in the
upcoming World Cup in June; she is one of the best in the
world."
Lloyd's deal with Yolked was negotiated by IMG on behalf of
Yolked and Carli's marketing team at WME.
About Carli
Lloyd
Carli Anne Lloyd
is an American soccer player, two-time Olympic gold medalist, FIFA
Women's World Cup champion, 2015 FIFA Player of the Year and 2016
FIFA Player of the Year. She currently plays for Sky Blue FC in the
NWSL and the United States Women's National Soccer Team, the most
successful team in international women's soccer. Lloyd became the
first person ever to score three goals in a FIFA Women's World Cup
final, and the second soccer player in history to score a hat trick
in any senior FIFA World Cup Final. She also scored the gold
medal-winning goals in the finals of the 2008 Summer Olympics and
the 2012 Summer Olympics.
About Yolked®
Yolked® is an NSF
Certified for Sport® all-natural sports nutrition
product that helps your body utilize protein more efficiently to
build more lean muscle in conjunction with resistance training. Its
key ingredient, Fortetropin®, is a proprietary
composition made from fertilized egg yolk through a patented
process that maintains its vital nutrients and bioactivity to build
more lean muscle and decrease muscle loss. For more information,
please visit www.yolked.com.
About MYOS RENS Technology Inc.
MYOS RENS
Technology Inc. (MYOS), "The Muscle Company®", is a
Cedar Knolls, NJ-based advanced
nutrition company that develops and markets products that improve
muscle health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin has been clinically shown to
increase muscle size and lean body mass in conjunction with
resistance training. MYOS believes Fortetropin has the potential to
redefine existing standards of physical health and wellness. For
more information, please visit www.MYOSRENS.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products, including
Qurr®, Yolked®, MYOS Enteral
Nutrition Formula™ and MYOS Canine Muscle
Formula® , the success of our research and
development, the results of the clinical evaluation
of Fortetropin® and its effects, the
ability to enter into new partnership opportunities and the success
of our existing partnerships, the ability to generate revenue and
cash flow from sales of our products, the ability to increase our
revenue and gross profit margins, the ability to achieve a
sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor Relations:
Porter LeVay & Rose
Matthew Abenante, IRC, SVP
Phone: 212-564-4700
Email: MYOS@plrinvest.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-announces-endorsement-partnership-for-yolked-with-carli-lloyd-two-time-olympic-gold-medalist-fifa-womens-world-cup-champion-and-captain-of-the-united-states-womens-national-soccer-team-300857741.html
SOURCE MYOS RENS Technology Inc.